DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $235,349,900 | -9.5% | 970,608 | -13.0% | 3.43% | -14.8% |
| Q2 2023 | $260,157,414 | +17.0% | 1,116,015 | +22.1% | 4.03% | -12.3% |
| Q1 2023 | $222,262,239 | +2.8% | 914,378 | +7.8% | 4.59% | -8.6% |
| Q4 2022 | $216,312,491 | +31.0% | 848,253 | +30.1% | 5.02% | +15.5% |
| Q3 2022 | $165,087,000 | +16.6% | 652,048 | +14.5% | 4.35% | +15.4% |
| Q2 2022 | $141,550,000 | +19.3% | 569,508 | +38.3% | 3.77% | +37.7% |
| Q1 2022 | $118,683,000 | -5.5% | 411,742 | +6.6% | 2.74% | -7.5% |
| Q4 2021 | $125,571,000 | -16.2% | 386,211 | -22.9% | 2.96% | -27.5% |
| Q3 2021 | $149,906,000 | +20.0% | 500,622 | +5.8% | 4.08% | +8.8% |
| Q2 2021 | $124,906,000 | +55.5% | 472,955 | +31.5% | 3.75% | +43.2% |
| Q1 2021 | $80,342,000 | +17.4% | 359,602 | +15.7% | 2.62% | -13.0% |
| Q4 2020 | $68,431,000 | +9.1% | 310,846 | +5.2% | 3.01% | -4.6% |
| Q3 2020 | $62,748,000 | +15.4% | 295,536 | +8.9% | 3.16% | +1.3% |
| Q2 2020 | $54,396,000 | +41.6% | 271,346 | -6.4% | 3.11% | +2.9% |
| Q1 2020 | $38,404,000 | -25.3% | 290,016 | -15.9% | 3.03% | +2.2% |
| Q4 2019 | $51,436,000 | +11.3% | 344,761 | +1.5% | 2.96% | +8.6% |
| Q3 2019 | $46,208,000 | -3.6% | 339,548 | -0.4% | 2.72% | -12.5% |
| Q2 2019 | $47,911,000 | +5.5% | 341,070 | -2.6% | 3.11% | +6.9% |
| Q1 2019 | $45,430,000 | +34.9% | 350,039 | +6.1% | 2.91% | +28.5% |
| Q4 2018 | $33,670,000 | -8.9% | 329,885 | -3.3% | 2.27% | +0.3% |
| Q3 2018 | $36,966,000 | +64.2% | 340,987 | +49.1% | 2.26% | +45.6% |
| Q2 2018 | $22,514,000 | +8.2% | 228,677 | +7.3% | 1.55% | +3.3% |
| Q1 2018 | $20,816,000 | +21.2% | 213,035 | +14.9% | 1.50% | +60.2% |
| Q4 2017 | $17,173,000 | +18.2% | 185,436 | +9.2% | 0.94% | +22.1% |
| Q3 2017 | $14,531,000 | +80.0% | 169,766 | +76.9% | 0.77% | +73.2% |
| Q2 2017 | $8,072,000 | +8.1% | 95,954 | +9.6% | 0.44% | +5.2% |
| Q1 2017 | $7,467,000 | +8.7% | 87,549 | -1.1% | 0.42% | +11.6% |
| Q4 2016 | $6,869,000 | +69.4% | 88,513 | +70.7% | 0.38% | +51.2% |
| Q3 2016 | $4,055,000 | -46.5% | 51,856 | -31.0% | 0.25% | -48.3% |
| Q2 2016 | $7,584,000 | +15.6% | 75,192 | +8.6% | 0.48% | -11.0% |
| Q1 2016 | $6,561,000 | +36.7% | 69,211 | +33.8% | 0.54% | +31.1% |
| Q4 2015 | $4,798,000 | +15.3% | 51,712 | +5.6% | 0.42% | +16.6% |
| Q3 2015 | $4,163,000 | -45.2% | 48,968 | -44.8% | 0.36% | -36.8% |
| Q2 2015 | $7,594,000 | -14.4% | 88,723 | -15.1% | 0.56% | -14.2% |
| Q1 2015 | $8,872,000 | -11.4% | 104,494 | -10.6% | 0.66% | -8.9% |
| Q4 2014 | $10,017,000 | -29.4% | 116,869 | -37.4% | 0.72% | -24.1% |
| Q3 2014 | $14,190,000 | -8.1% | 186,759 | -4.8% | 0.95% | -2.1% |
| Q2 2014 | $15,447,000 | +23.7% | 196,204 | +17.9% | 0.97% | +9.9% |
| Q1 2014 | $12,483,000 | +27.4% | 166,434 | +31.1% | 0.88% | +28.0% |
| Q4 2013 | $9,802,000 | +12.6% | 126,974 | +1.1% | 0.69% | +5.8% |
| Q3 2013 | $8,707,000 | -22.8% | 125,601 | -29.5% | 0.65% | -28.3% |
| Q2 2013 | $11,278,000 | – | 178,165 | – | 0.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |